# Bicycle Therapeutics plc: insider transactions

BCYC · Nasdaq · CIK 1761612 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/bcyc.md) · [Financials](/companies/bcyc/financials.md) · [Filings](/companies/bcyc/filings.md) · [Insiders](/companies/bcyc/insiders.md)

## All transactions: 10

Non-derivative transactions reported on Forms 4, newest first. Codes P (purchase) and S (sale) are open-market trades. Reported price is as stated on the form, not a market price. Filter with ?type= `open-market`, `purchase`, `sale`.

| Date | Insider | Role | Transaction | Shares | Reported price | Value | Filing |
| --- | --- | --- | --- | ---: | ---: | ---: | --- |
| 2020-07-15 | [Glaxosmithkline plc](/insiders/1131399.md) | 10% owner | Sale (S) | 78 | $19.25 | $1.5k | [Form 4](/filings/0001387131-20-008376.md) |
| 2020-07-15 | [Glaxosmithkline plc](/insiders/1131399.md) | 10% owner | Sale (S) | 3,069 | $19.4016 | $59.5k | [Form 4](/filings/0001387131-20-008376.md) |
| 2020-07-14 | [Glaxosmithkline plc](/insiders/1131399.md) | 10% owner | Sale (S) | 1,597 | $19.274 | $30.8k | [Form 4](/filings/0001387131-20-008376.md) |
| 2019-05-28 | [Glaxosmithkline plc](/insiders/1131399.md) | Director, 10% owner | Purchase (P) | 385,714 | $14.00 | $5.4m | [Form 4](/filings/0000903423-19-000235.md) |
| 2019-05-28 | [Glaxosmithkline plc](/insiders/1131399.md) | Director, 10% owner | Conversion (C) | 636,366 | not reported | not reported | [Form 4](/filings/0000903423-19-000235.md) |
| 2019-05-28 | [Glaxosmithkline plc](/insiders/1131399.md) | Director, 10% owner | Conversion (C) | 893,195 | not reported | not reported | [Form 4](/filings/0000903423-19-000235.md) |
| 2019-05-28 | [Novartis Bioventures Ltd](/insiders/1297709.md) | 10% owner | Purchase (P) | 168,630 | $14.00 | $2.4m | [Form 4](/filings/0001104659-19-032920.md) |
| 2019-05-28 | [Novartis Bioventures Ltd](/insiders/1297709.md) | 10% owner | Conversion (C) | 636,366 | not reported | not reported | [Form 4](/filings/0001104659-19-032920.md) |
| 2019-05-28 | [Novartis Bioventures Ltd](/insiders/1297709.md) | 10% owner | Option exercise (in the money) (X) | 71,450 | not reported | not reported | [Form 4](/filings/0001104659-19-032920.md) |
| 2019-05-28 | [Novartis Bioventures Ltd](/insiders/1297709.md) | 10% owner | Conversion (C) | 893,195 | not reported | not reported | [Form 4](/filings/0001104659-19-032920.md) |

Source: SEC EDGAR, Forms 4. Last ingested by Listed: Oct 29, 2026, 07:25 ET. No prices; not investment advice.